The Benchmark Indices closed in the green on Tuesday, with the Sensex experiencing a gain of 51.7 points or nearly 0.06 percent, ending the day at 80,716.55, and the Nifty 50 index closed in green by nearly 0.11 percent or 26.3 points higher, to close at 24,613.
The Nifty 50 index moved up by 0.84 percent over the previous five trading sessions, while the Sensex climbed by about 0.75 percent.
Following are the five stocks for which brokerages recommended an upside of up to 43 percent.
Global Health Limited
With a market capitalisation of Rs. 32,457.2 crore, the shares of one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India moved up by nearly 1% on BSE to hit an intraday high at Rs. 1,222.6 in the trading session of Tuesday, against its previous closing price of Rs. 1,211.25.
The analysts of brokerage firm JM Financial gave a ‘buy’ rating on Global Health with a target price of Rs. 1,465 per share, representing a potential upside of 21 percent from Tuesday’s closing price of Rs. 1,208.8.
Incorporated in 2004, Global Health Limited is engaged in the business of providing healthcare services, with key specialties including cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.
Fortis Healthcare Limited
With a market capitalisation of Rs. 36,872.2 crore, the shares of a leading integrated healthcare delivery service provider in India moved up by 1.6 percent on BSE to hit an intraday high at Rs. 494 in the trading session of Tuesday, against its previous closing price of Rs. 486.05.
The analysts of brokerage firm JM Financial gave a ‘buy’ rating on Fortis Healthcare with a target price of Rs. 595 per share, representing a potential upside of nearly 22 percent from Tuesday’s closing price of Rs. 488.4.
Incorporated in 1996, Fortis Healthcare Limited is primarily engaged in the business of healthcare services. The healthcare verticals of the company primarily comprise hospitals, diagnostics and daycare specialty facilities.
Vinati Organics Limited
With a market capitalisation of Rs. 19,899.6 crore, the stock moved up by 0.6 percent on BSE to hit an intraday high at Rs. 1,925 in the trading session of Tuesday, against its previous closing price of Rs. 1,914.
The analysts of brokerage firm Motilal Oswal gave a ‘buy’ rating on Vinati Organics with a target price of Rs. 2,340 per share, representing a potential upside of nearly 22 percent from Tuesday’s closing price of Rs. 1,919.6.
Established in 1989, Vinati Organics Limited is engaged in the business of manufacturing speciality chemicals.
Gabriel India Limited
With a market capitalisation of Rs. 7,137.7 crore, the shares of a pioneer of Ride Control Products in India moved up by 3.3 percent on BSE to hit an intraday high at Rs. 506 in the trading session of Tuesday, against its previous closing price of Rs. 489.8.
The analysts of brokerage firm Elara Capital gave a ‘buy’ rating on Gabriel India with a target price of Rs. 624 per share, representing a potential upside of nearly 26 percent from Tuesday’s closing price of Rs. 496.9.
Incorporated in 1961, Gabriel India Limited, a flagship company of the ANAND Group, is engaged in the manufacturing and sale of auto components. It offers a wide range of ride control products including shock absorbers, struts & front forks, catering to all segments of the automotive industry.
The company is a leading manufacturer of shock absorbers for new-generation vehicles in the 2 & 3-wheeler segment in India, including electric vehicles (EVs).
GPT Healthcare Limited
With a market capitalisation of Rs. 1,402.7 crore, the stock moved up by 4.7 percent on BSE to hit an intraday high at Rs. 173.3 in the trading session of Tuesday, against its previous closing price of Rs. 165.55.
The analysts of brokerage firm JM Financial gave a ‘buy’ rating on GPT Healthcare with a target price of Rs. 245 per share, representing a potential upside of nearly 43 percent from Tuesday’s closing price of Rs. 170.95.
GPT Healthcare Limited, the healthcare arm of the GPT Group, is engaged in Healthcare Services including running of hospitals and providing medical services.
The company operates a chain of mid-sized full-service hospitals under the brand name of “ILS Hospitals” and provides integrated healthcare services, with a focus on secondary and tertiary care.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
